BRIDION (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the BRIDION drug offered from Merck Sharp & Dohme Corp.. This gamma-Cyclodextrins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | sugammadex |
| SUBSTANCE NAME: | SUGAMMADEX SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | gamma-Cyclodextrins [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-12-15 |
| END MARKETING DATE: | 0000-00-00 |
BRIDION HUMAN PRESCRIPTION DRUG Details:
| Item Description | BRIDION from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/mL) |
| START MARKETING DATE: | 2015-12-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-5423_dc8ac7d3-52d0-4e6b-b301-04f0013ddbaf |
| PRODUCT NDC: | 0006-5423 |
| APPLICATION NUMBER: | NDA022225 |
Other SUGAMMADEX SODIUM Pharmaceutical Manufacturers / Labelers:
